Literature DB >> 16765704

Histologic correlation of in vivo optical coherence tomography images of the human retina.

Teresa C Chen1, Barry Cense, Joan W Miller, Peter A D Rubin, Daniel G Deschler, Evangelos S Gragoudas, Johannes F de Boer.   

Abstract

PURPOSE: To correlate in vivo human retina optical coherence tomography (OCT)3 images with histology.
DESIGN: Case series.
METHODS: Linear OCT3 scans through the macula and optic nerve were obtained in three eyes of three patients who then underwent exenteration surgery for orbital cancers. OCT3 images were then correlated with histology.
RESULTS: On histology, two eyes were normal, and one eye had dry macular degeneration. The plexiform layers on histology correlated with the green/yellow areas on the OCT3 scans, and the nuclear layers correlated with the black areas on the OCT3 scans.
CONCLUSIONS: The authors are unaware of previous reports correlating histology to in vivo human retina OCT3 images. Our findings using human eyes are not different from previous animal studies, in that the plexiform layers are optically highly backscattering and the nuclear layers are not.

Entities:  

Mesh:

Year:  2006        PMID: 16765704     DOI: 10.1016/j.ajo.2006.01.086

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  37 in total

1.  Qualitative and quantitative OCT response of diffuse diabetic macular oedema to macular laser photocoagulation.

Authors:  R Vemala; S Koshy; S Sivaprasad
Journal:  Eye (Lond)       Date:  2011-04-15       Impact factor: 3.775

2.  Association between integrity of foveal photoreceptor layer and visual acuity in branch retinal vein occlusion.

Authors:  Masafumi Ota; Akitaka Tsujikawa; Tomoaki Murakami; Mihori Kita; Kazuaki Miyamoto; Atsushi Sakamoto; Noritatsu Yamaike; Nagahisa Yoshimura
Journal:  Br J Ophthalmol       Date:  2007-05-15       Impact factor: 4.638

3.  Association between foveal photoreceptor status and visual acuity after resolution of diabetic macular edema by pars plana vitrectomy.

Authors:  Atsushi Sakamoto; Kazuaki Nishijima; Mihori Kita; Hideyasu Oh; Akitaka Tsujikawa; Nagahisa Yoshimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-09       Impact factor: 3.117

Review 4.  Spectral domain optical coherence tomography and glaucoma.

Authors:  Teresa C Chen; Audrey Zeng; Wei Sun; Mircea Mujat; Johannes F de Boer
Journal:  Int Ophthalmol Clin       Date:  2008

5.  Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis.

Authors:  R T Naismith; N T Tutlam; J Xu; J B Shepherd; E C Klawiter; S-K Song; A H Cross
Journal:  Neurology       Date:  2009-07-07       Impact factor: 9.910

6.  Choroidal thickness in relation to sex, age, refractive error, and axial length in healthy Turkish subjects.

Authors:  Ibrahim Tuncer; Eyyup Karahan; Mehmet Ozgur Zengin; Eray Atalay; Nihat Polat
Journal:  Int Ophthalmol       Date:  2014-06-21       Impact factor: 2.031

7.  Influence of coherence length, signal-to-noise ratio, log transform, and low-pass filtering on layer thickness assessment with OCT in the retina.

Authors:  Nomdo M Jansonius; Joel Cervantes; Maddipatla Reddikumar; Barry Cense
Journal:  Biomed Opt Express       Date:  2016-10-07       Impact factor: 3.732

8.  Choroidal thickness in patients with diabetic retinopathy analyzed by spectral-domain optical coherence tomography.

Authors:  Caio V Regatieri; Lauren Branchini; Jill Carmody; James G Fujimoto; Jay S Duker
Journal:  Retina       Date:  2012-03       Impact factor: 4.256

9.  Choroidal thickness in normal eyes measured using Cirrus HD optical coherence tomography.

Authors:  Varsha Manjunath; Mohammad Taha; James G Fujimoto; Jay S Duker
Journal:  Am J Ophthalmol       Date:  2010-06-29       Impact factor: 5.258

Review 10.  OPTICAL COHERENCE TOMOGRAPHY AND HISTOLOGY OF AGE-RELATED MACULAR DEGENERATION SUPPORT MITOCHONDRIA AS REFLECTIVITY SOURCES.

Authors:  Katie M Litts; Yuhua Zhang; K Bailey Freund; Christine A Curcio
Journal:  Retina       Date:  2018-03       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.